111 related articles for article (PubMed ID: 18992885)
21. Purification of a conjugated polysaccharide vaccine using tangential flow diafiltration.
Emami P; Motevalian SP; Pepin E; Zydney AL
Biotechnol Bioeng; 2019 Mar; 116(3):591-597. PubMed ID: 30450582
[TBL] [Abstract][Full Text] [Related]
22. Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges.
Frasch CE
Vaccine; 2009 Oct; 27(46):6468-70. PubMed ID: 19555714
[TBL] [Abstract][Full Text] [Related]
23. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides.
Shafer DE; Toll B; Schuman RF; Nelson BL; Mond JJ; Lees A
Vaccine; 2000 Jan; 18(13):1273-81. PubMed ID: 10649629
[TBL] [Abstract][Full Text] [Related]
24. Protective activity of a glycoconjugate based on a synthetic hexasaccharide related to a fragment of capsular Streptococcus pneumoniae serotype 14 polysaccharide chain.
Kurbatova EA; Vorob'ev DS; Akhmatov EA; Akhmatova NK; Egorova NB; Tsvetkov YE; Sukhova EV; Yashunskii DV; Nifant'ev NE
Bull Exp Biol Med; 2014 Sep; 157(5):612-5. PubMed ID: 25257424
[TBL] [Abstract][Full Text] [Related]
25. Introduction of air in the anaerobic culture of Streptococcus pneumoniae serotype 23F induces the release of capsular polysaccharide from bacterial surface into the cultivation medium.
Gonçalves VM; Takagi M; Carneiro SM; de Campos Giordano R; Tanizaki MM
J Appl Microbiol; 2006 Nov; 101(5):1009-14. PubMed ID: 17040224
[TBL] [Abstract][Full Text] [Related]
26. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
[TBL] [Abstract][Full Text] [Related]
27. Strategies for type-specific glycoconjugate vaccines of Streptococcus pneumoniae.
Arndt B; Porro M
Adv Exp Med Biol; 1991; 303():129-48. PubMed ID: 1805561
[No Abstract] [Full Text] [Related]
28. Divide and conquer: division of labor by B-1 B cells.
Alugupalli KR; Gerstein RM
Immunity; 2005 Jul; 23(1):1-2. PubMed ID: 16039572
[TBL] [Abstract][Full Text] [Related]
29. Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications.
Jacques S; Rich JR; Ling CC; Bundle DR
Org Biomol Chem; 2006 Jan; 4(1):142-54. PubMed ID: 16358009
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and immunochemical characterization of protein conjugates of carbohydrate and carbohydrate-mimetic peptides as experimental vaccines.
Hossany RB; Johnson MA; Eniade AA; Pinto BM
Bioorg Med Chem; 2004 Jul; 12(13):3743-54. PubMed ID: 15186860
[TBL] [Abstract][Full Text] [Related]
31. A single-step method for the production of sugar hydrazides: intermediates for the chemoselective preparation of glycoconjugates.
Flinn NS; Quibell M; Monk TP; Ramjee MK; Urch CJ
Bioconjug Chem; 2005; 16(3):722-8. PubMed ID: 15898743
[TBL] [Abstract][Full Text] [Related]
32. On the preparation of carbohydrate-protein conjugates using the traceless Staudinger ligation.
Grandjean C; Boutonnier A; Guerreiro C; Fournier JM; Mulard LA
J Org Chem; 2005 Sep; 70(18):7123-32. PubMed ID: 16122231
[TBL] [Abstract][Full Text] [Related]
33. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.
Poolman J; Kriz P; Feron C; Di-Paolo E; Henckaerts I; Miseur A; Wauters D; Prymula R; Schuerman L
Vaccine; 2009 May; 27(24):3213-22. PubMed ID: 19446194
[TBL] [Abstract][Full Text] [Related]
34. Mitigating base-catalysed degradation of periodate-oxidized capsular polysaccharides: Conjugation by reductive amination in acidic media.
Zou W; Williams D; Cox A
Vaccine; 2019 Feb; 37(8):1087-1093. PubMed ID: 30678850
[TBL] [Abstract][Full Text] [Related]
35. Parameters underlying distinct T cell-dependent polysaccharide-specific IgG responses to an intact gram-positive bacterium versus a soluble conjugate vaccine.
Colino J; Chattopadhyay G; Sen G; Chen Q; Lees A; Canaday DH; Rubtsov A; Torres R; Snapper CM
J Immunol; 2009 Aug; 183(3):1551-9. PubMed ID: 19570830
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology.
Wu X; Bundle DR
J Org Chem; 2005 Sep; 70(18):7381-8. PubMed ID: 16122263
[TBL] [Abstract][Full Text] [Related]
37. Rapid and complete adsorption of unconjugated protein from protein-polysaccharide conjugate vaccines.
Shafer DE; Schuman RF; Lees A
Vaccine; 2001 Jan; 19(11-12):1547-58. PubMed ID: 11163681
[TBL] [Abstract][Full Text] [Related]
38. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
39. Expanding polysaccharide-protein coupling of glycoconjugate vaccines.
Berti F
J Biol Chem; 2022 Mar; 298(3):101755. PubMed ID: 35202656
[TBL] [Abstract][Full Text] [Related]
40. The C-type lectin CD209b is expressed on microglia and it mediates the uptake of capsular polysaccharides of Streptococcus pneumoniae.
Park JY; Choi HJ; Prabagar MG; Choi WS; Kim SJ; Cheong C; Park CG; Chin CY; Kang YS
Neurosci Lett; 2009 Feb; 450(3):246-51. PubMed ID: 19095040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
